Qube Research & Technologies LTD Amphastar Pharmaceuticals, Inc. Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Amphastar Pharmaceuticals, Inc. stock. As of the latest transaction made, Qube Research & Technologies LTD holds 206,219 shares of AMPH stock, worth $9.55 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
206,219
Previous 125,835
63.88%
Holding current value
$9.55 Million
Previous $5.53 Million
49.29%
% of portfolio
0.01%
Previous 0.01%
Shares
9 transactions
Others Institutions Holding AMPH
# of Institutions
280Shares Held
34.3MCall Options Held
25.5KPut Options Held
24.8K-
Black Rock Inc. New York, NY5.94MShares$275 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.67MShares$124 Million0.0% of portfolio
-
Federated Hermes, Inc. Pittsburgh, PA1.94MShares$90.1 Million0.19% of portfolio
-
Td Asset Management Inc1.69MShares$78.4 Million0.07% of portfolio
-
Neuberger Berman Group LLC New York, NY1.62MShares$75.2 Million0.05% of portfolio
About Amphastar Pharmaceuticals, Inc.
- Ticker AMPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 49,015,200
- Market Cap $2.27B
- Description
- Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-count...